Marc Krattinger
Direktor/Vorstandsmitglied bei Strongwind Holding AG
Ursprung des Netzwerks ersten Grades von Marc Krattinger
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Aravis AG
Aravis AG Investment ManagersFinance Aravis AG (Aravis) is an independent venture capital firm, founded in 2001 by Jean-Philippe Tripet and headquartered in Muttenz, Switzerland.
12
| Private Company | Investment Managers | 12 |
Strongwind Holding AG
Strongwind Holding AG Electric UtilitiesUtilities Strongwind Holding AG owns and operates wind park. The company is headquartered in Zurich, Switzerland.
2
| Private Company | Electric Utilities | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Marc Krattinger
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Luminor Harbour Fund 1 Pte Ltd. | Director/Board Member | ||
QT VASC | Medical Specialties | Director/Board Member | |
Quattro Vascular Pte Ltd. | Director/Board Member | ||
Myanmar Carlsberg Co. Ltd. | Director/Board Member | ||
Merge Pacific Sdn. Bhd. | Director/Board Member | ||
Maida Vale Consulting Group Pte Ltd. | Director/Board Member | ||
Luminor Capital Beijing Co. Ltd. | Director/Board Member | ||
Chinese Business Exchange Pte Ltd. | Director/Board Member | ||
Celltwo, Inc. Pte. Ltd. | Director/Board Member | ||
Luminor Pacific Fund 2 Ltd.
Luminor Pacific Fund 2 Ltd. Investment ManagersFinance Luminor Pacific Fund 2 Ltd seeks investment opportunities in companies located in Asia Pacific region. The fund focuses in the companies operating in the fields of healthcare, resources, consumer, lifestyle and infrastructure sectors. It provides financing for the private equity capital requirements. | Investment Managers | Director/Board Member | |
Luminor Pacific Fund 1 Ltd.
Luminor Pacific Fund 1 Ltd. Investment ManagersFinance Luminor Pacific Fund 1 Ltd. seeks investment opportunities in the companies located in Asia Pacific region. The fund focuses in the companies operating in the fields of resources, renewable energy and recombinant technology sectors. It provides for private equity capital requirements. | Investment Managers | Director/Board Member | |
Sano V Pte. Ltd. | Director/Board Member | ||
Multiple Lodge Sdn. Bhd. | Director/Board Member | ||
Luminor Capital Australia Pty Ltd. | Director/Board Member | ||
Ayondo Asia Pte Ltd. | Director/Board Member | ||
Queen's University of Belfast | College/University | Doctorate Degree | |
AYONDO LTD. | Internet Software/Services | Director/Board Member | |
King Wai Group Pte Ltd.
King Wai Group Pte Ltd. Financial ConglomeratesFinance King Wai Group Pte Ltd. operates as a Singaporean investment company. | Financial Conglomerates | Director/Board Member | |
ANCHOR RESOURCES LIMITED | Precious Metals | Director/Board Member | |
NEXT GENERATION FINANCE INVEST AG | Financial Conglomerates | Director/Board Member | |
Luminor Capital Pte Ltd.
Luminor Capital Pte Ltd. Investment ManagersFinance Luminor Capital Pte Ltd. is private equity firm founded in 2008 by Fatt Kah Foo and Chee Seng Kwan. The firm is headquartered in Singapore. | Investment Managers | Founder | |
Singapore Medtech Accelerator Pte Ltd.
Singapore Medtech Accelerator Pte Ltd. Medical SpecialtiesHealth Technology Singapore Medtech Accelerator Pte Ltd. manufactures medical devices. The private company is based in Singapore, Singapore. The Singaporean company was founded by Eitan Konstantino. | Medical Specialties | Director/Board Member | |
VCPLUS LIMITED | Precious Metals | Director/Board Member | |
TopiVert Ltd.
TopiVert Ltd. BiotechnologyHealth Technology TopiVert Ltd. develops topical treatments for inflammatory diseases of the eye and gut. Its application is used in the treatment of asthma, chronic obstructive pulmonary disease, and cystic fibrosis and other inflammatory diseases of the lungs. The company was founded by Eric Charles Meldrum in 2011 and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member | |
LiMM Therapeutics SA
LiMM Therapeutics SA Financial ConglomeratesFinance LiMM Therapeutics SA operates as a biopharmaceutical corporation, that specializes in molecular cross-talk between neuronal and innate lymphoid cells within peripheral tissues. The firm develops medicines against inflammatory, infectious, and metabolic diseases. The company was founded by David Braga Malta and Henrique Veiga Fernandes and is headquartered in Paris, France. | Financial Conglomerates | Chairman | |
University of Sherbrooke | College/University | Doctorate Degree | |
Inception IBD, Inc.
Inception IBD, Inc. Miscellaneous Commercial ServicesCommercial Services Inception IBD, Inc. provides therapeutics services. It creates new companies in partnership with pioneering academic researchers and major biopharmaceutical companies, which provide funding and a path to liquidity through pre-negotiated acquisitions. The company was founded by Eric Ogier-Denis, Yoram Bouhnik, Xavier Treton and Jacques Mizrahi in 2011 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Founder | |
ELSALYS BIOTECH | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Eyevensys SAS
Eyevensys SAS Miscellaneous Commercial ServicesCommercial Services Eyevensys SAS develops non-viral gene therapy process for the treatment of ocular illnesses. The firm's process enables prolonged production of all therapeutic proteins through electrotransfer. Its product, the single-used device is designed for treating ocular illnesses. The company was founded by Francine Behar-Cohen on December 8, 2008 and is headquartered in Paris, France. | Miscellaneous Commercial Services | Director/Board Member | |
Reichmuth & Co. Investment Management AG
Reichmuth & Co. Investment Management AG Investment ManagersFinance Reichmuth & Co. Investment Management AG is the asset management subsidiary of Reichmuth & Co. Holding AG in Switzerland. Headquartered in Lucerne, the firm provides investment and pension solutions for high-net worth individuals and their families, corporations and institutional clients. | Investment Managers | Portfolio Manager-Equities | |
CytoKi Pharma ApS
CytoKi Pharma ApS Miscellaneous Commercial ServicesCommercial Services CytoKi Pharma ApS engages in the research and experimental development within biotechnology. It develops therapeutics for serious tissue and organ injuries. The company was founded by Rasmus Jørgensen on June 12, 2019 and is headquartered in Vaerlose, Denmark. | Miscellaneous Commercial Services | Director/Board Member | |
Vandria SA
Vandria SA Pharmaceuticals: MajorHealth Technology Vandria SA is a Swiss-based company that specializes in mitochondrial therapeutics. The company is based in Lausanne, Switzerland. The company is developing mitophagy inducers that rejuvenate cells to treat age-related and chronic diseases. Its lead program, VNA-318, is a brain-penetrant, patent-protected, mitophagy inducer that has shown to improve memory and learning and to have strong disease-modifying effects in models of neurodegenerative diseases such as Alzheimer's and Parkinson's disease. Vandria is also developing mitophagy-inducing small molecules to address muscle, lung, and liver diseases, as well as a separate program that targets ferroptosis. The company was founded by Patrick Aebischer, Chris Rinsch, and Johan Auwerx in 2021 and has raised $20.60m in venture finance. Klaus Dugi has been the CEO of the company since 2021. | Pharmaceuticals: Major | Director/Board Member | |
IP Group Plc /Venture Capital/
IP Group Plc /Venture Capital/ Investment ManagersFinance IP Group Plc /Venture Capital/ (IP Group) is a venture capital subsidiary of IP Group Plc founded in 2001. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor | |
NanoDimension Management Ltd.
NanoDimension Management Ltd. Investment ManagersFinance NanoDimension Management (NanoDimension) Ltd is a venture capital firm founded in 2002 by Aymeric Sallin. The firm is headquartered in George Town. | Investment Managers | Private Equity Investor | |
Akamis Bio Ltd.
Akamis Bio Ltd. BiotechnologyHealth Technology Akamis Bio Ltd. operates as a biotechnology company which develops novel therapeutics that addresses cancer and other clinically unmet diseases. Its products include Enadenotucirev, Espindolol and AbEnAd. The firm also develops treatments based upon the research phase vaccine platform PolySTAR, which combines recombinant viral vectors with polymers to shield them from the immune system, and the research phase adjuvant and immunotherapeutic platform PolyMAP, which combines polymers with synthetic adjuvants to significantly enhance the effectiveness of vaccines. The company was founded by Andrew Justin Stewart Coats and Stefan D. Anker on November 17, 2006 and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Director/Board Member | |
Biosingapore
Biosingapore Miscellaneous Commercial ServicesCommercial Services Biosingapore operates as an association of life science businesses. The private company is based in Singapore, Singapore. | Miscellaneous Commercial Services | Treasurer | |
Crescendo Biologics Ltd.
Crescendo Biologics Ltd. Miscellaneous Commercial ServicesCommercial Services Crescendo Biologics Ltd. engages in the development of new medicines based on antibody fragment technology. Its products in pipeline in dermatology include CB001, a transformational Humabody-based topical biologic for psoriasis which combines exceptional activity against a validated target with a topical route of delivery to avoid systemic side effects. The firm?s oncology products in pipeline include Humabody Multi-Specific T-Cell Engagers, Humabody Antibody Drug Conjugates and Immune Checkpoint Inhibitors. The company was founded by Michael Anthony Romanos, David Rayll Brown and John Bradshaw on November 13, 2007 and is headquartered in Cambridge, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
Touchstone Innovations Investment Management Ltd.
Touchstone Innovations Investment Management Ltd. Investment ManagersFinance Touchstone Innovations Investment Management Ltd. is a Venture Capital firm, a subsidiary of Touchstone Innovations Ltd. founded in 1986. Touchstone Innovations Investment Management Ltd. is headquartered in London. | Investment Managers | Director/Board Member | |
Escuela de Organización Industrial | College/University | Masters Business Admin | |
University of Barcelona | College/University | Doctorate Degree | |
Minoryx Therapeutics SL
Minoryx Therapeutics SL BiotechnologyHealth Technology Minoryx Therapeutics SL engages in the development of drugs for the orphan genetic diseases of the central nervous system. The company was founded by Marc Martinell, Joan Aymami, Nigel Ten Fleming and Xavier Barril in 2011 and is headquartered in Barcelona, Spain. | Biotechnology | Director/Board Member | |
Index Ventures SA
Index Ventures SA Investment ManagersFinance Index Ventures SA (Index Ventures) is a venture capital firm founded in 1996 by Neil Alexander Rimer, Gluseppe Zocco and Gerald Rimer. The firm is headquartered in Geneva, Switzerland. | Investment Managers | Private Equity Analyst | |
Singapore Institute of Directors | Corporate Officer/Principal | ||
Sg Securities Asia Ltd. | Corporate Officer/Principal | ||
Amira Properties Sdn. Bhd.
Amira Properties Sdn. Bhd. Financial ConglomeratesFinance Part of Luminor Capital Pte Ltd., Amira Properties Sdn. Bhd. provides investment services. | Financial Conglomerates | Director/Board Member |
Statistik
International
Singapur | 21 |
Schweiz | 7 |
Vereinigtes Königreich | 7 |
Malaysia | 4 |
Frankreich | 4 |
Sektoral
Finance | 14 |
Health Technology | 10 |
Commercial Services | 6 |
Consumer Services | 5 |
Technology Services | 3 |
Operativ
Director/Board Member | 69 |
Private Equity Investor | 19 |
Corporate Officer/Principal | 16 |
Chairman | 8 |
Doctorate Degree | 8 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Marc Krattinger
- Unternehmensverbindungen